Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - Clinical infectious …, 2008 - academic.oup.com
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Vulvar intraepithelial neoplasia: Classification, epidemiology, diagnosis, and management

M Lebreton, I Carton, S Brousse, V Lavoué… - Journal of Gynecology …, 2020 - Elsevier
Vulvar intraepithelial neoplasia (VIN) is classified into two entities: differentiated (dVIN) and
vulvar high-grade squamous intraepithelial lesions (vH-SIL). dVIN is a premalignant lesion …

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the …

M Preti, E Joura, P Vieira-Baptista… - International Journal of …, 2022 - ijgc.bmj.com
The European Society of Gynaecological Oncology (ESGO), the International Society for the
Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval …

Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV)

F Aubin, JL Prétet, AC Jacquard… - Clinical Infectious …, 2008 - academic.oup.com
Background. External acuminata condylomata (EAC) are among the most common sexually
transmitted diseases. Although it is understood that low-risk human papillomavirus (HPV) …

Genital warts and cost of care in England

S Desai, S Wetten, SC Woodhall, L Peters… - Sexually transmitted …, 2011 - sti.bmj.com
Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …

Epidemiology and cost of treatment of genital warts in Spain

X Castellsagué, C Cohet… - … European Journal of …, 2009 - academic.oup.com
Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …

Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France

C Bergeron, N Largeron, R McAllister… - International journal of …, 2008 - cambridge.org
Objectives: A vaccine to prevent diseases due to human papillomavirus (HPV) types 6, 11,
16, and 18 is now available in France. The objective of this study was to assess the health …

Appraisal of the burden of genital warts from a healthcare and individual patient perspective

CDS Lefebvre, G Van Kriekinge, MA Gonçalves… - Public health, 2011 - Elsevier
OBJECTIVE: Worldwide, genital warts, caused by human papillomavirus (HPV) is a
common, sexually transmitted disease. The overall disease management strategy for genital …

Cost–consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles

S Capri, R Gasparini, D Panatto, N Demarteau - Gynecologic oncology, 2011 - Elsevier
OBJECTIVES: Two human papillomavirus (HPV) vaccines are currently available: a bivalent
HPV-16/18 and a quadrivalent HPV-6/11/16/18 vaccine. The vaccines may have different …

[HTML][HTML] Vulval premalignant lesions: a review article

S Gupta, S Ahuja, DS Kalwaniya… - Obstetrics & …, 2024 - ncbi.nlm.nih.gov
Vulvar intraepithelial neoplasia (VIN) is a noninvasive squamous lesion that is a precursor of
vulvar squamous cell cancer. Currently, no screening tests are available for detecting VIN …